Patents by Inventor Christopher Logg

Christopher Logg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240327866
    Abstract: Provided herein are recombinant virus systems comprising two or more coordinatedly regulated viral vectors. Methods for treating a cell proliferative disorder using these systems are also provided. The compositions and methods provided herein provide more efficient and coordinated delivery of larger transgenes and/or larger quantities of a tansgene than previous methods by avoiding receptor interference and/or superinfection resistance, thereby enabling progressive replication of both vectors and efficient gene delivery by each vector.
    Type: Application
    Filed: July 21, 2022
    Publication date: October 3, 2024
    Applicant: The Regents of the University of California
    Inventors: Noriyuki Kasahara, Sara A. Collins, Alexander F. Haddad, Manish Aghi, Christopher Logg
  • Publication number: 20050287129
    Abstract: Vector compositions and methods are provided for transfecting donor cell populations and tissues for grafts, for reducing expression of mismatched proteins, thereby reducing immunogenicity of the grafted cells and tissues in a recipient subject.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 29, 2005
    Inventors: James Cicciarelli, Noriyuki Kasahara, Christopher Logg
  • Patent number: 6899871
    Abstract: A recombinant replication competent retrovirus for gene deliver and gene therapy is provided. The recombinant retrovirus has a heterologous nucleic acid sequence, a sequence encoding a cell- or tissue-specific ligand or a sequence for transcriptional targeting, or a combination of both a cell- or tissue-specific ligand and a cell- or tissue-specific transcriptional targeting sequence.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: May 31, 2005
    Assignee: University of Southern California
    Inventors: Noriyuki Kasahara, Christopher Logg, W. French Anderson
  • Publication number: 20050002903
    Abstract: A recombinant replication competent retrovirus for gene deliver and gene therapy is provided. The recombinant retrovirus has a heterologous nucleic acid sequence, a sequence encoding a cell- or tissue-specific ligand or a sequence for transcriptional targeting, or a combination of both a cell- or tissue-specific ligand and a cell- or tissue-specific transcriptional targeting sequence.
    Type: Application
    Filed: January 11, 2002
    Publication date: January 6, 2005
    Inventors: Noriyuki Kasahara, Christopher Logg, W. Anderson